# Canton Strategic Holdings, Inc.: financial statements, quarterly

CNTN · Nasdaq · CIK 1861657 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cntn.md) · [Financials](/companies/cntn/financials.md) · [Filings](/companies/cntn/filings.md) · [Insiders](/companies/cntn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cntn/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [1.5](/filings/0001493152-26-038044.md) |
| Research and development | $m | [0.5](/filings/0001493152-24-044063.md) | [1.0 d](/filings/0001641172-25-000654.md) | [1.0](/filings/0001641172-25-009569.md) | [1.0](/filings/0001641172-25-023745.md) | [2.3](/filings/0001493152-25-021991.md) | [2.1 d](/filings/0001493152-26-013861.md) | [0.6](/filings/0001493152-26-022629.md) | [0.1](/filings/0001493152-26-038044.md) | [0.3](/filings/0001493152-25-021991.md) | [1.7 d](/filings/0001493152-26-013861.md) | [0.3](/filings/0001493152-26-022629.md) | not reported |
| Operating income | $m | [(1.8)](/filings/0001493152-24-044063.md) | [(2.5) d](/filings/0001641172-25-000654.md) | [(2.3)](/filings/0001641172-25-009569.md) | [(2.4)](/filings/0001641172-25-023745.md) | [(3.9)](/filings/0001493152-25-021991.md) | [(3.8) d](/filings/0001493152-26-013861.md) | [(2.5)](/filings/0001493152-26-022629.md) | [(1.4)](/filings/0001493152-26-038044.md) | [(2.1)](/filings/0001493152-25-021991.md) | [(13.6) d](/filings/0001493152-26-013861.md) | [(36.9)](/filings/0001493152-26-022629.md) | [(1.2)](/filings/0001493152-26-038044.md) |
| Interest expense | $m | [0.0](/filings/0001493152-23-039775.md) | [0.0 d](/filings/0001493152-24-007612.md) | [0.0](/filings/0001493152-24-018338.md) | [0.0](/filings/0001641172-25-023745.md) | [0.0](/filings/0001493152-25-021991.md) | [0.0 d](/filings/0001493152-26-013861.md) | [0.0](/filings/0001493152-26-022629.md) | [0.0](/filings/0001493152-26-038044.md) | [0.0](/filings/0001493152-25-021991.md) | [0.0 d](/filings/0001493152-26-013861.md) | not reported | not reported |
| Income tax | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [(4.2)](/filings/0001493152-26-022629.md) | [(6.7)](/filings/0001493152-26-038044.md) |
| Net income | $m | [(1.8)](/filings/0001493152-24-044063.md) | [(2.5) d](/filings/0001641172-25-000654.md) | [(2.3)](/filings/0001641172-25-009569.md) | [(2.3)](/filings/0001641172-25-023745.md) | [(3.8)](/filings/0001493152-25-021991.md) | [(3.8) d](/filings/0001493152-26-013861.md) | [(2.5)](/filings/0001493152-26-022629.md) | [(1.9)](/filings/0001493152-26-038044.md) | [(2.1)](/filings/0001493152-25-021991.md) | [(29.4) d](/filings/0001493152-26-013861.md) | [(47.3)](/filings/0001493152-26-022629.md) | [(19.3)](/filings/0001493152-26-038044.md) |
| Diluted EPS | $ per share | [(39.42)](/filings/0001493152-24-044063.md) | not reported | [(2.55)](/filings/0001641172-25-009569.md) | [(2.42)](/filings/0001641172-25-023745.md) | [(2.45)](/filings/0001493152-25-021991.md) | not reported | [(0.99)](/filings/0001493152-26-022629.md) | [(0.64)](/filings/0001641172-25-023745.md) | [(0.34)](/filings/0001493152-25-021991.md) | not reported | [(0.23)](/filings/0001493152-26-022629.md) | not reported |
| Basic EPS | $ per share | [(39.42)](/filings/0001493152-24-044063.md) | not reported | [(2.55)](/filings/0001641172-25-009569.md) | [(2.42)](/filings/0001641172-25-023745.md) | [(2.45)](/filings/0001493152-25-021991.md) | not reported | [(0.99)](/filings/0001493152-26-022629.md) | [(0.64)](/filings/0001641172-25-023745.md) | [(0.34)](/filings/0001493152-25-021991.md) | not reported | [(0.23)](/filings/0001493152-26-022629.md) | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [2.7](/filings/0001493152-23-039775.md) | [10.9](/filings/0001493152-24-044063.md) | [8.4](/filings/0001493152-24-018338.md) | [7.9](/filings/0001493152-24-030936.md) | [4.8](/filings/0001493152-24-044063.md) | [3.6](/filings/0001493152-25-021991.md) | [1.1](/filings/0001641172-25-009569.md) | [2.2](/filings/0001641172-25-023745.md) | [7.6](/filings/0001493152-25-021991.md) | [12.0](/filings/0001493152-26-038044.md) | [41.5](/filings/0001493152-26-022629.md) | [37.2](/filings/0001493152-26-038044.md) |
| Current assets | $m | [3.2](/filings/0001493152-23-039775.md) | [10.9](/filings/0001641172-25-000654.md) | [8.9](/filings/0001493152-24-018338.md) | [8.3](/filings/0001493152-24-030936.md) | [5.3](/filings/0001493152-24-044063.md) | [3.7](/filings/0001493152-26-013861.md) | [1.7](/filings/0001641172-25-009569.md) | [2.5](/filings/0001641172-25-023745.md) | [7.7](/filings/0001493152-25-021991.md) | [17.4](/filings/0001493152-26-038044.md) | [43.1](/filings/0001493152-26-022629.md) | [41.2](/filings/0001493152-26-038044.md) |
| Total assets | $m | [3.2](/filings/0001493152-23-039775.md) | [10.9](/filings/0001641172-25-000654.md) | [8.9](/filings/0001493152-24-018338.md) | [8.3](/filings/0001493152-24-030936.md) | [5.3](/filings/0001493152-24-044063.md) | [3.7](/filings/0001493152-26-013861.md) | [1.7](/filings/0001641172-25-009569.md) | [2.5](/filings/0001641172-25-023745.md) | [7.7](/filings/0001493152-25-021991.md) | [519](/filings/0001493152-26-038044.md) | [585](/filings/0001493152-26-022629.md) | [565](/filings/0001493152-26-038044.md) |
| Current liabilities | $m | [1.4](/filings/0001493152-23-039775.md) | [1.8](/filings/0001641172-25-000654.md) | [1.8](/filings/0001493152-24-018338.md) | [1.6](/filings/0001493152-24-030936.md) | [2.2](/filings/0001493152-24-044063.md) | [2.4](/filings/0001493152-26-013861.md) | [2.5](/filings/0001641172-25-009569.md) | [2.2](/filings/0001641172-25-023745.md) | [1.5](/filings/0001493152-25-021991.md) | [3.3](/filings/0001493152-26-038044.md) | [1.1](/filings/0001493152-26-022629.md) | [2.6](/filings/0001493152-26-038044.md) |
| Total liabilities | $m | [1.4](/filings/0001493152-23-039775.md) | [1.8](/filings/0001641172-25-000654.md) | [1.8](/filings/0001493152-24-018338.md) | [1.6](/filings/0001493152-24-030936.md) | [2.2](/filings/0001493152-24-044063.md) | [2.4](/filings/0001493152-26-013861.md) | [2.5](/filings/0001641172-25-009569.md) | [2.2](/filings/0001641172-25-023745.md) | [1.5](/filings/0001493152-25-021991.md) | [121](/filings/0001493152-26-038044.md) | [115](/filings/0001493152-26-022629.md) | [110](/filings/0001493152-26-038044.md) |
| Shareholders' equity | $m | [1.8](/filings/0001493152-24-044063.md) | [9.1](/filings/0001493152-26-013861.md) | [7.0](/filings/0001641172-25-023745.md) | [6.7](/filings/0001493152-25-021991.md) | [3.0](/filings/0001493152-25-021991.md) | [1.3](/filings/0001493152-26-038044.md) | [(0.8)](/filings/0001493152-26-038044.md) | [0.4](/filings/0001493152-26-038044.md) | [6.2](/filings/0001493152-25-021991.md) | [398](/filings/0001493152-26-038044.md) | [470](/filings/0001493152-26-038044.md) | [455](/filings/0001493152-26-038044.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(0.9) d](/filings/0001493152-24-044063.md) | [(1.4) d](/filings/0001641172-25-000654.md) | [(2.8)](/filings/0001641172-25-009569.md) | [(2.2) d](/filings/0001641172-25-023745.md) | [(2.9) d](/filings/0001493152-25-021991.md) | [(3.0) d](/filings/0001493152-26-013861.md) | [(2.7)](/filings/0001493152-26-022629.md) | [(1.1) d](/filings/0001493152-26-038044.md) | [(1.9) d](/filings/0001493152-25-021991.md) | [(10.4) d](/filings/0001493152-26-013861.md) | [(7.6)](/filings/0001493152-26-022629.md) | [(2.2) d](/filings/0001493152-26-038044.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [11.5](/filings/0001493152-23-039775.md) | [0.5](/filings/0001493152-24-018338.md) | [0.0](/filings/0001493152-24-030936.md) | [0.0](/filings/0001493152-24-044063.md) | [0.9](/filings/0001641172-25-009569.md) | [1.0](/filings/0001641172-25-023745.md) | [1.5](/filings/0001493152-25-021991.md) | [2.6](/filings/0001493152-26-022629.md) | [2.9](/filings/0001493152-26-038044.md) | [6.2](/filings/0001493152-25-021991.md) | [208](/filings/0001493152-26-022629.md) | [217](/filings/0001493152-26-038044.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 79,681,361 at 2026-08-13, from the cover of the [10-Q filed 2026-08-14](/filings/0001493152-26-038044.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.